GreenLight Biosciences Holdings, PBC Common Stock
GRNA
GRNA was delisted on the 21st of July, 2023.
68 hedge funds and large institutions have $173M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 15 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
3.11% more ownership
Funds ownership: 81.26% → 84.37% (+3.1%)
4% more capital invested
Capital invested by funds: $166M → $173M (+$6.88M)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
3% less funds holding
Funds holding: 70 → 68 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$7.81M |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$6.09M |
| 3 |
FTCM
Fir Tree Capital Management
New York
|
+$2.61M |
| 4 |
USPCM
Union Square Park Capital Management
New York
|
+$2.52M |
| 5 |
KC
Kepos Capital
New York
|
+$2.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
-$5.93M |
| 2 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$5.78M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.26M |
| 4 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$3.85M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.84M |
GRNA Hedge Fund Activity: Q4 2021 in Review
68 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q4 2021, worth a combined $173M — up 4.1% from $166M a quarter earlier.
Fund positioning in GRNA was balanced in Q4 2021: 15 funds opened new positions, 15 closed out, 14 added to existing stakes and 11 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $7.81M. The largest seller was Telemark Asset Management, exiting entirely with an estimated $5.93M sold.
- 68 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q4 2021, down from 70 in Q3 2021.
- Funds reported $173M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q4 2021, up 4.1% quarter-over-quarter.
- 15 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q4 2021 and 15 closed out, a net change of 0 holders.
- The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q4 2021 was Marshall Wace, an estimated $7.81M added.
- The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q4 2021 was Telemark Asset Management, an estimated $5.93M sold.
Based on aggregated 13F filings for Q4 2021.